Menu

Head of Global Health Security Ousted from White House

The position was eliminated the same week a new Ebola outbreak was declared in the Democratic Republic of the Congo.

May 10, 2018
Shawna Williams

Tim ZiemerWIKIMEDIA, CDC GLOBALTim Ziemer, a member of the White House’s National Security Council (NSC) who was in charge of global health security, abruptly left his post on Tuesday (May 8), the Huffington Post reports. An NSC spokesperson tells the publication that the change reflected a reorganization, and that Ziemer departed “on the warmest of terms.”

“It is unclear in his absence who at the White House would be in charge of a pandemic,” Beth Cameron of the Nuclear Threat Initiative tells the Huffington Post, calling it “a situation that should be immediately rectified.” Cameron was a senior director for global health security and biodefense on the previous administration’s NSC staff.

See “CDC to Drastically Cut Efforts to Prevent Global Disease Outbreaks

The departure occured the same day that the World Health Organization announced a new outbreak of Ebola in the Democratic Republic of the Congo. During a 2014–2015 outbreak of the virus that killed more than 11,000 people in West Africa, the US Congress had set aside funds to combat the epidemic; in another announcement made Tuesday, the White House proposed that Congress take back $252 million of that allocation.

Ron Klain, the former “Ebola czar” who coordinated the response of President Barack Obama’s administration to the earlier outbreak, tells The Atlantic that “having some money left over was intentional,” as it allows the United States Agency for International Development (USAID) to move quickly to try to contain future disease events. He adds that “if Congress accepts Trump’s proposal, USAID will have no funding for a response when the next crisis comes, and it will have to wait until Congress passes new funding, or diverts funds from some other, then-existing disaster response. . . . It is crazily short-sighted to do this.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.